{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:34:52Z","timestamp":1761514492287,"version":"build-2065373602"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005153","name":"China National Funds for Distinguished Young Scientists","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005153","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.bmcl.2019.126874","type":"journal-article","created":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T11:45:29Z","timestamp":1575459929000},"page":"126874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Synthesis and evaluation of 4-(1,3,4-oxadiazol-2-yl)-benzenesulfonamides as potent carbonic anhydrase inhibitors"],"prefix":"10.1016","volume":"30","author":[{"given":"Chaofu","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingxia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenwang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7826-2973","authenticated-orcid":false,"given":"Xinhua","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2019.126874_b0005","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1021\/cr050262p","article-title":"Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and Protein Ligand binding","volume":"108","author":"Krishnamurthy","year":"2008","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmcl.2019.126874_b0010","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ejmech.2018.03.030","article-title":"Synthesis of novel 4-functionalized 1,5-diaryl-1,2,3-triazoles containing benzenesulfonamide moiety as carbonic anhydrase I, II, IV and IX inhibitors","volume":"150","author":"Vats","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2019.126874_b0015","doi-asserted-by":"crossref","first-page":"6428","DOI":"10.1021\/acs.jmedchem.7b00766","article-title":"3-Hydroxy-1 H-quinazoline-2, 4-dione as a new scaffold to develop potent and selective inhibitors of the tumor-associated carbonic anhydrases IX and XII","volume":"60","author":"Falsini","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmcl.2019.126874_b0020","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ejmech.2017.11.061","article-title":"Inhibitory effects and structural insights for a novel series of coumarin-based compounds that selectively target human CA IX and CA XII carbonic anhydrases","volume":"143","author":"Luca","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2019.126874_b0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejmech.2014.06.074","article-title":"Synthesis of a new series of N 4-substituted 4-(2-aminoethyl) benzenesulfonamides and their inhibitory effect on human carbonic anhydrase cytosolic isozymes I and II and transmembrane tumorassociated isozymes IX and XII","volume":"84","author":"Slawinski","year":"2014","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2019.126874_b0030","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.bmcl.2019.126874_b0035","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1016\/j.bmcl.2016.11.017","article-title":"Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides","volume":"26","author":"Arslan","year":"2016","journal-title":"Bioorg Med Chem Lett"},{"issue":"5","key":"10.1016\/j.bmcl.2019.126874_b0040","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1517\/13543776.10.5.575","article-title":"Carbonic anhydrase inhibitors and their therapeutic potential","volume":"10","author":"Supuran","year":"2005","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.bmcl.2019.126874_b0045","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1016\/j.bmc.2010.03.082","article-title":"NO-releasing esters show carbonic anhydrase inhibitory action against human isoforms I and \u2161","volume":"18","author":"Ekinci","year":"2010","journal-title":"Bioorgan Med Chem"},{"key":"10.1016\/j.bmcl.2019.126874_b0050","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1152\/japplphysiol.01572.2005","article-title":"Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness","volume":"102","author":"Leaf","year":"2007","journal-title":"J Appl Physiol"},{"issue":"2","key":"10.1016\/j.bmcl.2019.126874_b0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148206","article-title":"Acute mountain sickness symptom severity at the south pole: the influence of self-selected prophylaxis with acetazolamide","volume":"11","author":"Harrison","year":"2016","journal-title":"PLoS ONE"},{"issue":"15","key":"10.1016\/j.bmcl.2019.126874_b0060","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.2174\/0929867325666180622120625","article-title":"State of the art on carbonic anhydrase modulators for biomedical purposes","volume":"26","author":"Bozdag","year":"2019","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmcl.2019.126874_b0065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejmech.2018.06.059","article-title":"Design of two-tail compounds with rotationally fixed benzenesulfonamide ring as inhibitors of carbonic anhydrases","volume":"156","author":"Zaksauskas","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmcl.2019.126874_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2019.115090","article-title":"Synthesis and exploration of 2-morpholino-4-phenylthiazol-5-yl acrylamide derivatives for their effects against carbonic anhydrase I, II, IX and XII isoforms as a non-sulfonamide class of inhibitors","volume":"27","author":"Swain","year":"2019","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmcl.2019.126874_b0075","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bioorg.2018.01.022","article-title":"Synthesis and biological evaluation of novel N, N\u2019-diaryl cyanoguanidines acting as potent and selective carbonic anhydrase II inhibitors","volume":"77","author":"Akocak","year":"2018","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2019.126874_b0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bioorg.2015.08.001","article-title":"Synthesis, biological evaluation, and docking studies of novel thiourea derivatives of bisindolylmethane as carbonic anhydrase II inhibitor","volume":"62","author":"Imran","year":"2015","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmcl.2019.126874_b0085","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1016\/j.bmc.2014.02.013","article-title":"Synthesis and methemoglobinemia-inducing properties of benzocaine isosteres designed as humane rodenticides","volume":"22","author":"Conole","year":"2014","journal-title":"Bioorg Med Chem"},{"issue":"6","key":"10.1016\/j.bmcl.2019.126874_b0090","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3109\/14756366.2014.983917","article-title":"Synthesis of 3,4-dihydroxypyrrolidine-2,5-dione and 3,5-dihydroxybenzoic acid derivatives and evaluation of the carbonic anhydrase I and \u2161 inhibition","volume":"30","author":"Arslan","year":"2015","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmcl.2019.126874_b0095","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.ijbiomac.2018.04.131","article-title":"Implication of sulfonylurea derivatives as prospective inhibitors of human carbonic anhydrase II","volume":"115","author":"Idrees","year":"2018","journal-title":"Int J Biol Macromol"}],"container-title":["Bioorganic &amp; Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X19308522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X19308522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T07:30:56Z","timestamp":1760772656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X19308522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0960894X19308522"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.126874","relation":{},"ISSN":["0960-894X"],"issn-type":[{"type":"print","value":"0960-894X"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and evaluation of 4-(1,3,4-oxadiazol-2-yl)-benzenesulfonamides as potent carbonic anhydrase inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2019.126874","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126874"}}